Alcyone Secures Funding to Advance Pediatric Neuro Therapies
April 24, 2025
Expanded collaboration with Nationwide Children’s Hospital adds new funding and a third therapeutic candidate (CLN-301) to Alcyone’s diversified portfolio of precision CNS therapeutics and delivery